Argus
•
May 27, 2026
CHE: Lowering target price to $459.00
Summary
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activitie
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: Mettler-Toledo International Inc.
May 28, 2026
•
MTD
Analyst Report: HCA Healthcare, Inc.
May 28, 2026
•
HCA
WST: Raising target price to $348.00
May 27, 2026
•
WST
LII: Raising target price to $553.00
May 27, 2026
•
LII
CSL: Raising target price to $324.00
May 27, 2026
•
CSL
